Io Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis (NCT06723171) | Io Therapeutics | 2026-03-01 |
| Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC (NCT02991651) | Io Therapeutics | 2016-12-07 |
| Study of IRX4204 for Treatment of Early Parkinson's Disease (NCT02438215) | Io Therapeutics | 2014-08-01 |
| Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer (NCT01540071) | Io Therapeutics | 2011-08-01 |
Track Io Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.